Zobrazeno 1 - 3
of 3
pro vyhledávání: '"Miller-Larsson, Anna"'
Autor:
Håkansson HF; Former employees of AstraZeneca R&D, Lund, Sweden. Hanna_fn@bredband.net, Smailagic A, Brunmark C, Miller-Larsson A, Lal H
Publikováno v:
Pulmonary pharmacology & therapeutics [Pulm Pharmacol Ther] 2012 Oct; Vol. 25 (5), pp. 399-406. Date of Electronic Publication: 2012 Aug 16.
Autor:
Kobayashi Y; Airway Disease Section, National Heart and Lung Institute, Imperial College London, Guy Scadding Building, Royal Brompton Campus, Dovehouse Street, London SW3 6LY, UK., Mercado N, Miller-Larsson A, Barnes PJ, Ito K
Publikováno v:
Pulmonary pharmacology & therapeutics [Pulm Pharmacol Ther] 2012 Jun; Vol. 25 (3), pp. 201-7. Date of Electronic Publication: 2012 Mar 02.
Autor:
Brange C; AstraZeneca R&D Lund, Scheelevagen 8, SE 221 87 Lund, Sweden. charlotte.brange@astrazeneca.com, Smailagic A, Jansson AH, Middleton B, Miller-Larsson A, Taylor JD, Silberstein DS, Lal H
Publikováno v:
Pulmonary pharmacology & therapeutics [Pulm Pharmacol Ther] 2009 Feb; Vol. 22 (1), pp. 20-6. Date of Electronic Publication: 2008 Nov 12.